Market Place
Sourcing Support
University Of West England Implements Heartsciences` Myovista
05 Feb 2026 //
GLOBENEWSWIRE
Heartsciences Updates Fiscal Q2 2026 Results & Business Progress
15 Dec 2025 //
GLOBENEWSWIRE
Heartsciences Submits Myovista Wavecg Device For FDA 510(K)
15 Dec 2025 //
GLOBENEWSWIRE
HeartSciences Launches Upgraded MyoVista Platform 1.1
11 Dec 2025 //
GLOBENEWSWIRE
HeartSciences Reports Q1 2026 Financial Results & Business Update
11 Sep 2025 //
GLOBENEWSWIRE
HeartSciences Announce Conference Participation, Investor Webinar
15 Aug 2025 //
GLOBENEWSWIRE
HeartSciences Reports Fiscal 2025 Business Update & Results
24 Jul 2025 //
GLOBENEWSWIRE
HeartSciences gets FDA Breakthrough for MyoVista Insights AI-ECG
04 Jun 2025 //
GLOBENEWSWIRE
HeartSciences Granted US Patent for ECG Technology
03 Jun 2025 //
GLOBENEWSWIRE
HeartSciences Signs First MyoVista Insights Platform Customer
29 May 2025 //
GLOBENEWSWIRE
HeartSciences CEO to Present at Emerging Growth Conference 82
20 May 2025 //
GLOBENEWSWIRE
HeartSciences Investor Webinar & Q&A on May 14, 2025 - CEO Andrew
08 May 2025 //
GLOBENEWSWIRE
HeartSciences Adds Key Advisors to Advisory Board
07 May 2025 //
GLOBENEWSWIRE
HeartSciences Launches MyoVista Insights Platform & Early Adopter
01 May 2025 //
GLOBENEWSWIRE
HeartSciences Updates Business and Reports Q3 Fiscal 2025 Results
13 Mar 2025 //
GLOBENEWSWIRE
HeartSciences Engages Integrous Communications to Enhance Invest
10 Mar 2025 //
GLOBENEWSWIRE
HeartSciences Provides Q2 FY25 Business Update
16 Dec 2024 //
GLOBENEWSWIRE
HeartSciences’ AI-ECG Receives CMS Medicare & Medicaid Approval
13 Nov 2024 //
GLOBENEWSWIRE
HeartSciences to Participate in 2024 Maxim Healthcare Virtual Summit
14 Oct 2024 //
GLOBENEWSWIRE
HeartSciences Secures Non-Dilutive Financing For FDA Submission
12 Sep 2024 //
GLOBENEWSWIRE
HeartSciences Reports Q1 Fiscal 2025 Results
12 Sep 2024 //
GLOBENEWSWIRE
HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results
29 Jul 2024 //
GLOBENEWSWIRE
HeartSciences Gets US Patent For AI-ECG Assessment Of Heart Dysfunction
11 Jul 2024 //
GLOBENEWSWIRE
HeartSciences Regains Compliance with Nasdaq Listing Requirements
04 Jun 2024 //
GLOBENEWSWIRE
HeartSciences Announces AI-ECG Patent Portfolio Internationalization
20 May 2024 //
GLOBENEWSWIRE
HeartSciences Gets AI-ECG Diastolic Function Patent in EU
24 Apr 2024 //
GLOBENEWSWIRE
HeartSciences Announces Completion of Patient Enrollment for FDA Pivotal Study
09 May 2023 //
GLOBENEWSWIRE
HeartSciences Reports Third Quarter Fiscal 2023 Financial Results
16 Mar 2023 //
GLOBENEWSWIRE
HeartSciences CEO Invited as Featured Guest on The Big Biz Show, February 7
07 Feb 2023 //
GLOBENEWSWIRE
HeartSciences Announces Further Internationalization of its Patent Portfolio
03 Feb 2023 //
GLOBENEWSWIRE
HeartSciences Reports Second Quarter Fiscal 2023 Financial Results
16 Dec 2022 //
GLOBENEWSWIRE
HeartSciences to Participate at Benchmark Discovery Investor Conference
21 Nov 2022 //
GLOBENEWSWIRE
HeartSciences Granted European Patent for Proprietary Electrode
25 Oct 2022 //
GLOBENEWSWIRE
HeartSciences Announces Major Milestone with the Issuance of CPT Codes
19 Oct 2022 //
GLOBENEWSWIRE
